PNNL's ASSORT model will help airports balance passenger screening and security risks with throughput. It also quantifies risks for different traveler types and optimizes checkpoint operations, improving efficiency while enhancing safety.

Armed with some of the world’s most advanced instrumentation, researchers at PNNL are working to analyze huge amounts of data and uncover hidden biological connections.

At the 2024 Aviation Futures Workshop, researchers from PNNL joined other subject matter experts and representatives from the stakeholder community in reimagining the passenger experience.

Researchers shared several technologies addressing urgent security challenges at the 2024 Homeland Protection Technologies Workshop at MIT Lincoln Laboratory, in Boston MA.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

One year ago, Verizon announced a partnership that made PNNL the U.S. Department of Energy’s first national laboratory with Verizon 5G ultra-wideband wireless technology.